Back
Albemarle Corp. 10K Form
Buy
52
ALB
Albemarle Corp.
Last Price:
$119.07
Seasonality Move:
1.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | ALB/Albemarle Corp. Quarterly |
| 2023-08-02 | 10Q | ALB/Albemarle Corp. Quarterly |
| 2023-05-03 | 10Q | ALB/Albemarle Corp. Quarterly |
| 2022-11-02 | 10Q | ALB/Albemarle Corp. Quarterly |
| 2022-08-03 | 10Q | ALB/Albemarle Corp. Quarterly |
| 2022-05-04 | 10Q | ALB/Albemarle Corp. Quarterly |
Receive ALB News And Ratings
See the #1 stock for the next 7 days that we like better than ALB
ALB Financial Statistics
Sales & Book Value
| Annual Sales: | $5.4B |
|---|---|
| Cash Flow: | $223.4M |
| Price / Cash Flow: | 142.69 |
| Annual Sales: | $65.94 |
| Price / Book: | 1.92 |
Profitability
| EPS (TTM): | -1.59680 |
|---|---|
| Net Income (TTM): | $21.7M |
| Gross Margin: | $60.2M |
| Return on Equity: | 0.21% |
| Return on Assets: | 0.13% |
Albemarle Corp. Earnings Forecast
Key Albemarle Corp. Financial Ratios
-
The Gross Profit Margin over the past 32 years for ALB is 1.12%.
-
The Selling, General & Administrative Expenses for ALB have been equal to 11.49% of Gross Profit Margin.
-
The Research & Development expenses have been 1.61% of Revenue.
-
The Net Earning history of ALB is -21.12% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 18 years.
Albemarle Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | ALB |
| CUSIP: | 012653 |
| Website: | albemarle.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 2.27 |
| Quick Ratio: | 1.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 5.73 |
|---|---|
| Forward P/E Ratio: | 154.06 |
ALB Technical Analysis vs Fundamental Analysis
Buy
52
Albemarle Corp. (ALB)
is a Buy
Is Albemarle Corp. a Buy or a Sell?
-
Albemarle Corp. stock is rated a BuyThe current Albemarle Corp. [ALB] share price is $119.14. The Score for ALB is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.